These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2014789)

  • 1. Thymidine labeling index versus Ki-67.
    Meyer JS
    Am J Clin Pathol; 1991 Apr; 95(4):602-4. PubMed ID: 2014789
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of Ki-67 and tritiated thymidine in measuring tumor proliferation.
    Verhoeven D; Buyssens N; Van Marck E
    Am J Clin Pathol; 1991 Apr; 95(4):602. PubMed ID: 2014788
    [No Abstract]   [Full Text] [Related]  

  • 3. A closer look at the cell cycle.
    Kreipe H; Parwaresch R
    Virchows Arch A Pathol Anat Histopathol; 1993; 422(5):341-3. PubMed ID: 8391734
    [No Abstract]   [Full Text] [Related]  

  • 4. [A simple method for flow cytometric measurement of Ki-67 reactive antigen on small solid tissues].
    Murakami T; Oga A; Uchiyama T; Kimura Y; Morimoto H; Suzuki T; Takahashi M
    Gan To Kagaku Ryoho; 1993 Apr; 20(6):737-40. PubMed ID: 7683864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PCNA immunopositivity index as a substitute to 3H-thymidine pulse-labeling index (TLI) in methanol-fixed human lymphocytes.
    Galand P; Del Bino G; Morret M; Capel P; Degraef C; Fokan D; Feremans W
    Leukemia; 1995 Jun; 9(6):1075-84. PubMed ID: 7596173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Little missed markers and Ki-67.
    Schwarting R
    Lab Invest; 1993 Jun; 68(6):597-9. PubMed ID: 8099985
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cell kinetic investigations in fibrocystic mastopathies and invasive breast carcinomas].
    Kunz J
    Acta Histochem Suppl; 1990; 39():175-9. PubMed ID: 2080259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistological detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues.
    Gerdes J; Becker MH; Key G; Cattoretti G
    J Pathol; 1992 Sep; 168(1):85-6. PubMed ID: 1453271
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunocytochemical detection of cell proliferation-related antigens in cytologic smears of human malignant neoplasms using PC10, reactive with proliferating cell nuclear antigen, and Ki-67. A comparative study.
    Pelosi G; Bresaola E; Manfrin E; Rodella S; Schiavon I; Iannucci A
    Arch Pathol Lab Med; 1994 May; 118(5):510-6. PubMed ID: 7910728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between labeling indices of Ki-67 and BrdUrd in human malignant tumors.
    Sasaki K; Matsumura K; Tsuji T; Shinozaki F; Takahashi M
    Cancer; 1988 Sep; 62(5):989-93. PubMed ID: 3409179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor proliferative fraction in solid malignant neoplasms. A comparative study of Ki-67 immunostaining and flow cytometric determinations.
    Sahin AA; Ro JY; el-Naggar AK; Wilson PL; Teague K; Blick M; Ayala AG
    Am J Clin Pathol; 1991 Oct; 96(4):512-9. PubMed ID: 1716414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferating cell nuclear antigen immunohistochemistry in rat aorta after balloon denudation. Comparison with thymidine and bromodeoxyuridine labeling.
    Zeymer U; Fishbein MC; Forrester JS; Cercek B
    Am J Pathol; 1992 Sep; 141(3):685-90. PubMed ID: 1381560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms.
    Goldblum JR; Shannon R; Kaldjian EP; Thiny M; Davenport R; Thompson N; Lloyd RV
    Mod Pathol; 1993 Nov; 6(6):663-8. PubMed ID: 7508113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of Ki-67 labeling index in urothelial tumors of the renal pelvis and ureter.
    Masuda M; Iki M; Takano Y; Asakura T; Noguchi S; Ikeda I; Kubota Y; Hosaka M
    J Urol; 1996 Jun; 155(6):1877-80; discussion 1880-1. PubMed ID: 8618278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ki-67 staining as a means to simplify analysis of tumor cell proliferation.
    Hitchcock CL
    Am J Clin Pathol; 1991 Oct; 96(4):444-6. PubMed ID: 1716412
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel method for estimating the labeling index in clinical specimens with the use of immunoperoxidase-labeled.
    Liebskind D; Hsu KC; Elequin F; Mendez L; Ghossein N; Janis M; Bases R
    Cancer Res; 1977 Jan; 37(1):323-6. PubMed ID: 318608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Flow cytometric analysis of Ki-67 reactive antigen].
    Murakami T; Sasaki K; Takahashi M
    Nihon Rinsho; 1992 Oct; 50(10):2355-9. PubMed ID: 1280305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of proliferating cells in acute leukemia with antibodies to proliferating cell nuclear antigen and Ki-67 monoclonal antibodies.
    Inoue T; Yamane T; Park K; Im T; Tatsumi N; Okuda K
    Arch Pathol Lab Med; 1993 Oct; 117(10):969-72. PubMed ID: 8105766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of proliferating cells by Ki-67 antibody.
    Baisch H; Gerdes J
    Methods Cell Biol; 1990; 33():217-26. PubMed ID: 2084469
    [No Abstract]   [Full Text] [Related]  

  • 20. Growth fraction in non-small cell lung cancer estimated by proliferating cell nuclear antigen and comparison with Ki-67 labeling and DNA flow cytometry data.
    Fontanini G; Pingitore R; Bigini D; Vignati S; Pepe S; Ruggiero A; Macchiarini P
    Am J Pathol; 1992 Dec; 141(6):1285-90. PubMed ID: 1361306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.